IND Swift Laboratories Ltd
INDSWFTLABIND Swift Laboratories Ltd
INDSWFTLAB
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 10.56 | 0.79 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.31 | 5.09 | 0.71% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Ind-Swift Laboratories Limited is a company focused on the development of active pharmaceutical ingredients (APIs).
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 682.83 | 667.85 | 737.46 | 784.01 | 876.44 | 813.04 | 914.04 | 1,082.23 | 1,240.81 | 1,248.54 | ||||||||||
Raw Materials | 393.23 | 352.08 | 377.52 | 374.40 | 421.46 | 409.10 | 457.35 | 581.87 | 673.70 | 1,000.20 | ||||||||||
| Power & Fuel Cost | 34.78 | 22.65 | 26.75 | 30.70 | 39.15 | 36.40 | 38.84 | 60.27 | 77.84 | |||||||||||
| Employee Cost | 54.73 | 66.85 | 69.65 | 88.12 | 97.63 | 102.72 | 106.55 | 127.09 | 135.84 | |||||||||||
| Selling & Administrative Expenses | 52.27 | 55.36 | 63.19 | 81.21 | 62.10 | 74.89 | 79.16 | 62.80 | 63.65 | |||||||||||
| Operating & Other expenses | 89.60 | 62.52 | 79.02 | 58.78 | 10.18 | 12.15 | 26.62 | 11.08 | 53.73 | |||||||||||
EBITDA | 58.22 | 108.39 | 121.33 | 150.80 | 245.92 | 177.78 | 205.52 | 239.12 | 236.05 | 248.34 | ||||||||||
| Depreciation/Amortization | 84.29 | 84.75 | 88.26 | 86.62 | 104.05 | 90.06 | 87.29 | 131.04 | 57.36 | 51.76 | ||||||||||
| PBIT | -26.07 | 23.64 | 33.07 | 64.18 | 141.87 | 87.72 | 118.23 | 108.08 | 178.69 | 196.58 | ||||||||||
| Interest & Other Items | 117.29 | 106.42 | 88.37 | 28.21 | 92.20 | 107.49 | 100.22 | 95.55 | 92.17 | 85.72 | ||||||||||
| PBT | -143.36 | -82.78 | -55.30 | 35.97 | 49.67 | -19.77 | 18.01 | 12.53 | 86.52 | 110.86 | ||||||||||
| Taxes & Other Items | -23.98 | -24.10 | -16.16 | 14.01 | 20.73 | 1.42 | 21.16 | 14.68 | 38.92 | 59.60 | ||||||||||
| Net Income | -119.38 | -58.68 | -39.14 | 21.96 | 28.94 | -21.19 | -3.15 | -2.15 | 47.60 | 51.26 | ||||||||||
| EPS | -29.76 | -14.33 | -9.12 | 4.86 | 6.21 | -3.96 | -0.53 | -0.36 | 8.03 | 8.65 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| IND Swift Laboratories Ltd | 11.38 | 0.79 | — |
| Sun Pharmaceutical Industries Ltd | 34.71 | 4.96 | 0.94% |
| Cipla Ltd | 34.93 | 4.13 | 0.70% |
| Dr Reddy's Laboratories Ltd | 21.38 | 4.14 | 0.69% |
Price Comparison
Compare INDSWFTLAB with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
High Pledged Promoter Holding
A significant proportion of promoter holdings is pledged
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
INDSWFTLAB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2011
Dividend/Share
₹1.00
Ex DateEx Date
Sep 20, 2011
Cash Dividend
Ex DateEx DateSep 16, 2010
Dividend/Share
₹1.00
Ex DateEx Date
Sep 16, 2010
News & Opinions
Why shares of PI Industries are down 8% today? Good time to buy?
2 years ago•Livemint
PI Industries decline after terminating business transfer agreement with Ind Swift
2 years ago•Business Standard
PI Industries: A Sizeable Entry Into Pharma
2 years ago•Moneycontrol
PI Industries to acquire Ind Swift’s API biz for Rs 1,530 cr
2 years ago•Free Press Journal
P I Industries to acquire API business of Ind Swift Laboratories
2 years ago•Business Standard
BRIEF-India’s IND Swift Laboratories Posts Dec-Quarter Consol Net PAT
2 years ago•Investing.com
BRIEF-Ind Swift Laboratories Posts Sept-Qtr Consol Net Profit - Investing.com India
3 years ago•Investing.com
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 9.62%, vs industry avg of 8.45%
Constant Market Share
Over the last 5 years, market share stayed at 0.39%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 16.73%, vs industry avg of 9.82%